Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) , were identified in general
population studies. Other mutation carrier-specific susceptibility variants
ASSOCIATIONS OF THE NRF2/KEAP1 PATHWAY AND ANTIOXIDANT DEFENSE GENE POLYMORPHISMS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEKorytina, G.F.,
Akhmadishina, L.Z.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Zagidullin, N.S.,
Kzhyshkowska, J.G.,
Zagidullin, S.Z.,
Viktorova, T.V. (2019) /KEAP1 signaling system, and antioxidant defense gene polymorphisms with COPD in
population from Russia
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, N.SH.,
ZAGIDULLIN, SH.Z.,
KZHYSHKOWSKA, J.G (2019) /KEAP1 signaling system, and antioxidant defense gene polymorphisms with COPD in
population from Russia
. The average incidence of NF1 in the world is 1:3000 of the
population. The characteristic signs of the disease